Pioneering Human + Machine Investing
Investment firms today have been unable to synergize quantitative and fundamental investing. Equity long/short funds with a quantamental approach operate a fundamental process with a bolt-on layer of data analysis. Quant funds incorporate key fundamental metrics and utilize alternative data mechanically, without the proper context of deep, company-specific research.
Both approaches fail to deliver a truly novel, best-of-both-worlds investment process.
An investment firm of tomorrow tomorrow
We are pioneering human + machine intelligence for investing
define
We begin from first-principles, defining the distinct areas where machine processing excels, and the ones where human insight has relative advantage.
update
This mapping of human and machine competencies is continuously updated based on advances in AI and machine capabilities, as well as advances in de-biasing human decision making.
refine
From this competency map, we develop a rigorous, data-intensive, semi-systematic investment process that we continuously refine over time.
What is Symbiosys?
In nature, symbiosis is the mutually beneficial interaction of two different species. They help one another in ways that are impossible in isolation, creating an ecosystem richer than the sum of its parts.
The name Symbiosys is a deliberate variation on the word symbiosis–we are combining (sym) human (bio) and machine (sys) trading into a symbiotic whole uncovering a new, more efficient investing paradigm.
Symbiosys Capital is an investing firm that is building a true synergy between fundamental and quantitative investing. It is creating a novel symbiosis between these two species.
About Us
The two co-founders of Symbiosys, Tseno Tselkov and David Gibson, have 40 years of combined experience managing investment businesses at leading alternative asset management firms.
Tseno was a senior Portfolio Manager at Ellington Management Group, an $11+ billion¹ multi-strategy hedge fund manager, where he ran a concentrated quantitative equities strategy.
David was a partner at D. E. Shaw & Co., a $50+ billion multi-strategy hedge fund, where he ran the firm’s event-driven equities strategies and served as the head of fundamental research.
The core framework and strategies underlying Symbiosys Capital were incubated at Ellington Management Group. Ellington’s key principals are backing the venture through a commitment to personally invest in the fund.
Our culture highlights deep collaboration and constant innovation
Our founding team consists of senior Portfolio Managers whose combined expertise includes both quantitative and fundamental investing. We believe that, in order to truly hybridize human and machine intelligence for investing, the founding team must bring deep knowledge and extensive experience in both areas.
Unique alpha generation starts from a unique perspective, firm culture, and talent base. Our firm operates more like a technology startup – with a pioneering mission, a focus on culture, and an environment of deep collaboration and constant innovation – than a traditional hedge fund.
Our internal culture consists of a commitment to the following values, which we look for in all prospective team members:
Dedication to life-long learning
Resourcefulness and passion for problem solving
Honesty, tenacity, positivity
Clear communication & collaboration
Diversity of backgrounds, thinking, and skill sets
